NewsBenzingaRezolute完成Ersodetug用于肿瘤性高胰岛素血症（HI）的开放标签3期研究入组；顶线数据预计于2026年12月中旬公布 Rezolute完成Ersodetug用于肿瘤性高胰岛素血症（HI）的开放标签3期研究入组；顶线数据预计于2026年12月中旬公布 Benzinga 2026.10.14 20:07 (GMT+0) Open on Benzinga Other news Why Is Snowflake Stock Surging Monday? 18 Globo Titles Heading To Netflix In Unprecedented Licensing Agreement ImmunityBio Study Shows Long-Term Success for Bladder Cancer Treatment RBC Capital Maintains Outperform on Regions Financial, Lowers Price Target to $32 Wells Fargo Maintains Equal-Weight on Greif, Lowers Price Target to $88 Piper Sandler Maintains Overweight on GCM Grosvenor, Lowers Price Target to $14.5
